MENU
+Compare
BHVN
Stock ticker: NYSE
AS OF
Jun 6, 01:56 PM (EDT)
Price
$17.11
Change
+$0.91 (+5.62%)
Capitalization
1.65B

BHVN Biohaven Ltd Forecast, Technical & Fundamental Analysis

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more

BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BHVN with price predictions
Jun 05, 2025

BHVN's RSI Indicator climbs out of oversold territory

The RSI Oscillator for BHVN moved out of oversold territory on June 02, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In of the 26 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 05, 2025. You may want to consider a long position or call options on BHVN as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BHVN just turned positive on June 03, 2025. Looking at past instances where BHVN's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BHVN advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

BHVN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHVN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BHVN entered a downward trend on June 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.373) is normal, around the industry mean (16.332). P/E Ratio (0.000) is within average values for comparable stocks, (59.787). BHVN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (263.647).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BHVN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BHVN is expected to report earnings to fall 12.44% to -189 cents per share on August 04

Biohaven Ltd BHVN Stock Earnings Reports
Q2'25
Est.
$-1.90
Q1'25
Missed
by $0.47
Q4'24
Missed
by $0.11
Q3'24
Missed
by $0.04
Q2'24
Missed
by $1.72
The last earnings report on May 12 showed earnings per share of -217 cents, missing the estimate of -170 cents. With 296.75K shares outstanding, the current market capitalization sits at 1.65B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JABAX47.34N/A
N/A
Janus Henderson Balanced T
IJSAX13.48N/A
N/A
VY® JPMorgan Small Cap Core Equity A
MWOIX65.12N/A
N/A
MFS Global Growth I
SACRX8.68N/A
N/A
Spirit of America Real Estate Inc&Gr C
VRMCX60.48N/A
N/A
Virtus KAR Mid-Cap Core R6

BHVN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with BEAM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
-0.06%
BEAM - BHVN
50%
Loosely correlated
-0.87%
CGON - BHVN
49%
Loosely correlated
+0.23%
SYRE - BHVN
49%
Loosely correlated
+0.54%
RVMD - BHVN
47%
Loosely correlated
-0.42%
OCUL - BHVN
46%
Loosely correlated
+0.95%
More